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Lipids from microorganisms are ligands of Toll like receptors (TLRs) and modulate the
innate immune response. Herein, we analyze in vitro the effect of total lipid extracts from
Trypanosoma cruzi amastigotes of RA and K98 strains (with polar biological behavior) on
the induction of the inflammatory response and the involvement of TLRs in this process.
We demonstrated that total lipid extracts from both strains induced lipid body formation,
cyclooxygenase-2 expression and TNF-α and nitric oxide release in macrophages, as
well as NF-κB activation and IL-8 release in HEK cells specifically through a TLR2/6
dependent pathway. We also evaluated the inflammatory response induced by total
lipid extracts obtained from lysed parasites that were overnight incubated to allow the
action of parasite hydrolytic enzymes, such as Phospholipase A1, over endogenous
phospholipids. After incubation, these total lipid extracts showed a significantly reduced
pro-inflammatory response, which could be attributed to the changes in the content of
known bioactive lipid molecules like lysophospholipids and fatty acids, here reported.
Moreover, analyses of total fatty acids in each lipid extract were performed by gas
chromatography-mass spectrometry. Our results indicate a relevant role of T. cruzi lipids
in the induction of a pro-inflammatory response through the TLR2/6 pathway that could
contribute to the modulation of the immune response and host survival.
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INTRODUCTION
Trypanosoma cruzi is the etiological agent of Chagas disease that represents a public health problem
in Latin America with a recent spreading to non-endemic areas due to human migration; it is
currently estimated that nearly 7 million people are infected by this protozoan parasite (WHO
Chagas disease (American trypanosomiasis), 2017)1. T. cruzi is highly heterogeneous in terms
1Available online at: http://www.who.int/mediacentre/factsheets/fs340/en/ (Accessed April 24, 2017).
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of genetics as well as biological behavior and great efforts
have been made to identify molecules involved in parasite–host
cell interaction, which may also contribute to the pathogenesis
of Chagas disease (Zingales et al., 2009). Amastigotes are the
replicative stage of this obligate intracellular parasite in the
mammalian host, which infect diverse cell types including
macrophages, and can form amastigote nests that when
degenerate lead to host cell destruction and inflammatory
processes with the consequent release of parasite enzymes (Melo
and Machado, 2001).
Phospholipids, major components of biomembranes, can
be enzymatically modified by the action of phospholipases
with generation of bioactive lipids that can act as second
messengers and also modulate the immune response. The first
evidences related to phospholipid degrading enzymes in T. cruzi
were associated to the inflammatory responses that appear
surrounding degenerating amastigote nests in various tissues
of Chagas disease patients, suggesting that the inflammation
observed might be attributed to phospholipid breakdown
products such as free fatty acids (FFA) and lysophospholipids
(Belaunzarán et al., 2011). In addition, we have already
demonstrated in all stages of T. cruzi RA strain a rapid and
extensive breakdown of endogenous phospholipids upon parasite
death, with a concomitant accumulation of FFA, that could be
attributed to T. cruzi Phospholipase A1 (Wainszelbaum et al.,
2001).
Macrophages initiate the innate immune response by
recognizing pathogens through pattern recognition receptors,
such as Toll-like receptors (TLRs). Besides, there are growing
evidences that point to a modulatory role of lipids from
diverse microorganisms in the innate immune response and
different members of the TLR family, particularly TLR1,
TLR2, TLR4, and TLR6, have been implicated in cell surface
recognition of lipids and lipid containing molecules (Roach
and Schorey, 2002; Akira and Takeda, 2004; Quesniaux et al.,
2004; Gimenez et al., 2010, 2016; Kawai and Akira, 2011).
Specifically, TLR2 recognizes a wide variety of pathogen-
associated molecular patterns (PAMPs) and forms heterodimers
with TLR1 or TLR6 to discriminate between different molecular
structures (Akira et al., 2006; Lee et al., 2012). Concerning
protozoa, it has been described that parasite molecules
from T. cruzi, T. brucei, Toxoplasma gondii, Leishmania
major, and Plasmodium falciparum are sensed by TLRs
(Gazzinelli and Denkers, 2006). As regards immune-stimulating
molecules of T. cruzi, it has been described that trypomastigote
mucin glycosylphosphatidylinositol (GPI) anchors are potent
stimulators of TLR2/6. In addition, glycoinosiltolphospholipids
(GIPLs), free GPI anchors, containing ceramide are recognized
by TLR4, while those containing alkylacylglycerol are agonists
of TLR2/6 (Cardoso et al., 2016). In the TLRs pathways, several
transcription factors including nuclear factor-kappa B (NF-κB)
are activated with the consequent induction of inflammatory
cytokines, chemokines and nitric oxide (NO) (Akira and Takeda,
2004). In this concern, NF-κB activation is a hallmark of cellular
response during T. cruzi infection where macrophages have an
essential role in the initial control of parasite replication, with
the production of inflammatory molecules such as IL-12, IL-8,
TNF-α as well as NO that possesses trypanocidal activity (Shoda
et al., 2001; Teixeira et al., 2002; Junqueira et al., 2010; Duque and
Descoteaux, 2014).
Host-pathogen interaction leads to the formation of lipid
bodies (LB) within cells from the immune system. These
dynamic organelles, present in the cytoplasm of most eukaryotic
cells, are critical regulators of different inflammatory diseases
and key markers of leukocyte activation. LB compartmentalize
eicosanoid forming enzymes like cyclooxygenase-2 (COX-
2), which regulates the production of diverse inflammatory
mediators (D’Avila et al., 2008; Bozza et al., 2009). In this regard,
it has been reported during T. cruzi infection that LB induction in
macrophages correlates with the concomitant increase of COX-2
expression (Melo et al., 2003; D’Avila et al., 2011).
In the present work, we investigated the effect of total
lipids extracts from T. cruzi amastigotes of two strains with
polar biological behavior, RA (high virulence) and K98 (low
virulence), as well as total lipids extracts obtained from lysed
parasites that were overnight incubated (to mimic the enzymatic
processes during amastigote nest degeneration where lipids
are modified), on the induction of an inflammatory response.
Furthermore, lipid modifications were analyzed by thin layer
chromatography and total fatty acids by gas chromatography-
mass spectrometry. To study the involvement of TLRs in this
process, we analyzed NF-κB activation and IL-8 secretion in HEK
transfected cells that expressed different combinations of TLRs
and were stimulated with the different lipid extracts. Besides,
the effect of all these lipids extracts were used to study in
murine peritoneal macrophages TNF-α and NO production, LB
induction and COX-2 expression.
MATERIALS AND METHODS
T. cruzi Amastigotes
Parasites from two T. cruzi strains that belong to different
Discrete Typing Units (DTUs): RA (Tc VI, high virulence) and
K98 (Tc I, low virulence) were used (González Cappa et al.,
1980, 1981; Zingales et al., 2009). To obtain culture amastigotes,
J774 E-clone macrophages were infected with bloodstream
trypomastigotes from each strain and grown in RPMI 1640
medium (Invitrogen, Grand Island, NY, USA)+ 10% fetal bovine
serum (Internegocios S.A., Bs. As., Arg.) at 37◦C and 5% CO2
(Belaunzarán et al., 2013).
Preparation of Total Lipid Extracts From
RA and K98 Amastigotes Homogenates
(RA, K98, RAinc, and K98inc)
Independent batches of amastigotes (1 × 109) of both strains
were harvested separately, washed, suspended in phosphate
buffer saline (PBS) + 1X protease inhibitor cocktail (Sigma-
Aldrich, St. Louis, MO, USA)+ 0.1% sodium azide and disrupted
by three freezing/thawing cycles (amastigote homogenates).
Then, the individual batches from each amastigote homogenate
were divided in two (5 × 108 parasites/each): (i) one of them
was incubated for 18 h at 37◦C, in order to mimic the enzymatic
processes that occur during amastigote nest degeneration where
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parasite lipids are modified (RAinc and K98inc), and (ii) the
other batch was used directly, with no incubation (RA and
K98). In all cases, total lipids were extracted according to Bligh
and Dyer (1959), solvents were evaporated with a stream of
nitrogen to constant weight and lipids were suspended in ethanol
(EtOH) (Merck, Darmstadt, Germany) for cell stimulation assays
or in chloroform (Merck) for lipid profile analysis, and stored at
−20◦C until used.
Analysis of Total Lipids From K98
Amastigotes
Equal amounts of both K98 and K98inc were separated by thin
layer chromatography (TLC) on silica gel 60 plates (Merck)
using a double solvent system as previously described (Florin-
Christensen et al., 2000). Lipids were identified by comparison
with authentic standards. For mass determination, plates were
sprayed with 10% CuSO4 in 8% H3PO4 and charred by exposure
to 150◦C for 13min (Baron et al., 1984). Densitometric analyses
were performedwith Gel-Pro R© Analyzer 4.0 (Media Cybernetics,
Inc., Silver Spring, MD, USA).
Analyses of Fatty Acids by Gas
Chromatography-Mass Spectrometry
(GC-MS)
The analyses of the fatty acids (FA) fractions by GC-MS were
carried out as previously described (Christie, 2011). Total lipids
extracts of parasites (RA, RAinc, K98 and K98inc) were obtained
as described above. Each lipid sample was dissolved in 1ml
toluene and 2ml of 1% sulfuric acid in methanol was added.
The mixture was left overnight in a stoppered tube at 50◦C,
then 1ml of 5% NaCl was added and the required esters were
extracted twice with 2ml hexane which was removed in a
stream of nitrogen. Dried fatty acid methyl esters (FAME) were
suspended in 100 µl heptane. GC/MS analyses were carried
out on a Shimadzu GCMS-QP2010 Plus system, using an
HP Ultra 2 (5% Phenyl-methylpolysiloxane), Agilent (25m ×
0.20mm× 0.33µm). Injector was set at 250◦C splitless. Column
temperature was programmed from 40 to 160◦C at 30◦C/min,
160–233◦C at 1◦C/min, 233–300◦C at 3◦C/min and held at 300◦C
for 10min. Helium was used as carrier gas with linear velocity of
36.0 cm s-1. A volume of 2ml of sample was injected into the
chromatograph. Electro ionization (EI-70 eV) and a quadrupole
mass analyzer, operated in scans from 40 to 440 amu. Interface
was set at 240◦C and the ion source at 240◦C. The components
were identified by comparing their mass spectra with those of the
library NIST05 contained in the computer’s mass spectrometer.
Retention indices were also used to confirm the identity of the
peaks in the chromatogram by Supelco 37 Component FAME
Mix (Sigma-Aldrich).
Effect of Chlorpromazine on Native T. cruzi
PLA1
Aliquots of amastigote homogenates (100 mg/assay) were
previously incubated with the T. cruzi PLA1 inhibitor
chlorpromazine (Wainszelbaum et al., 2001) (GlaxoSmithKline
Pharmaceuticals, Harlow, UK) at different concentrations (2.5,
5.0, and 10.0mM), for 30min, at room temperature and then
incubated for 5 h at 37◦C. Lipids were extracted and separated by
TLC using the double solvent system described above, lipid spots
were identified by comparison with commercial standards and
mass determination was carried out as described. Densitometric
analyses of the lipid spots were performed with Gel-Pro R©
Analyzer 4.0.
Effect of Recombinant T. cruzi PLA1 on
Amastigotes Total Lipids
Cloning and Expression of Recombinant T. cruzi
PLA1 in a Baculovirus Expression Vector System
The DNA sequence of T. cruzi PLA1 previously cloned
(Belaunzarán et al., 2013), was then cloned into the baculovirus
expression vector system using Bac-to-bac methodology
according to the supplier’s suggestions (Thermo Fisher Scientific
Inc., Rockford, IL, USA). Briefly, the plasmid pGEMT-TcPLA1
was used as template to amplify the entire open reading frame of
T. cruzi PLA1 gene (GenBank Accession number: JN975637.1)
by PCR. using the specific primers 5′ CTC GAG AAC ATG
CGC CGC CGC CGC A 3′ and 5′ AAG CTT TCA GTG ATG
GTG ATG GTG ATG AGA CTC TCT GTG ACG CGC 3′
which incorporated 5′and 3′ sites for the restriction enzymes
XhoI and HindIII, respectively. The 1.029 bp PCR product
corresponding to T. cruzi PLA1 was cloned into pGEM-T
easy vector (Promega Corporation, Madison, WI, USA) and
sub-cloned into pFastBac1 (pFB1) donor vector (Thermo Fisher
Scientific Inc.) using Xho I and Hind III, under the control
of polyhedrin promoter. The transfer vectors (pFB1-T. cruzi
PLA1) were used to transform DH10Bac cells (Thermo Fisher
Scientific Inc.,). White colonies were selected by addition of
kanamycin, tetracycline and gentamycin in the presence of IPTG
and Bluo-Gal.The presence of the transgene and absence of not-
recombinant DNA was confirmed by PCR using M13 forward
andM13 reverse primers. The correct recombinant bacmid DNA
was transfected to Sf9 cells derived from the fall armyworm
Spodoptera frugiperda, using Cellfectin II transfection reagent,
according to the manufacturer’s instructions (Thermo Fisher
Scientific Inc.,). Transfection supernatants were collected after
5 days and the viral stocks were tittered by end point dilution
(O’Reilly et al., 1994).
For expression of recombinant T. cruzi PLA1, Sf9 cells
were infected with high-titer virus stock previously obtained
and harvested at 48–96 h post-infection. For T. cruzi PLA1
purification, cells were washed twice with PBS, suspended in
lysis buffer (50mM NaH2PO4, 300mM NaCl, 10mM Imidazole,
pH 7.6) in the presence of 1X protease cocktail inhibitor and
incubated at 4◦C for 30min. The lysate was centrifuged at
10,000 × g for 20min at 4◦C and the clear supernatant was
collected and filtered through 0.45µm membrane and then
loaded onto a nickel resin column (Thermo Fisher Scientific
Inc.). Recombinant T. cruzi PLA1 was eluted by pH gradient
using 50mM NaH2PO4, 300mM NaCl, pH 4 to 5. Aliquots were
analyzed by SDS-PAGE, Comassie blue staining, immunoblot
and phospholipase activity (Reisfeld et al., 1994; Belaunzarán
et al., 2013).
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Analysis of Amastigote Lipid Degradation by
Recombinant T. cruzi PLA1
Amastigotes (1 × 109), RA strain, were washed thrice in PBS,
suspended in 10mM Tris with protease inhibitors (1X protease
cocktail inhibitor; 0.5mMTLCK, 2.5mM E-64) and disrupted by
five cycles of freezing and thawing. Total lipids were extracted
as described (Bligh and Dyer, 1959), solvents were evaporated
with a stream of nitrogen to constant weight and lipids were
then suspended in 0.2M sodium acetate, pH 4.7. Then, 500 µl
of total lipid suspensions (5 mg/ml) were incubated with 200 µl
of recombinant T. cruzi PLA1 (700µg/ml) or 200 µl of elution
buffer as control, at 37◦C for 18 h. Lipids were extracted and
separated by TLC using a double solvent system and identified
by comparison with commercial standards. Mass determination
and densitometric analyses of the lipid spots were performed as
described above.
Human Embryonic Kidney 293A Cells
Adherent Clone (HEK 293A Cells)
HEK 293A cells were cultured in high-glucose Dulbecco’s
modified Eagle medium supplemented with 10% fetal bovine
serum (FBS) in the absence of antibiotics, at 37◦C and 5% CO2.
These cells were used to evaluate TLRs participation in NF-κB
activation and IL-8 release triggered by the different lipid extracts.
TLRs Transfection Assay of HEK 293A Cells
TLRs transfection ofHEK 293A cells was performed as previously
described (Carneiro et al., 2013). Briefly, 5 × 105cells/well
were seeded into 12-well plates for 24 h at 37◦C, 5% CO2
and then transfected using Lipofectamine 2000 and Opti-
MEM (Invitrogen) according to manufacturer’s instructions. To
analyze TLR2/6, TLR2/1 and TLR4 involvement, the following
combinations of plasmid constructs were used: (A) TLR2,
TLR6, CD14, CD36, MD-2, Firefly luciferase reporter construct
driven by a NF-κB-dependent promoter (Firefly), β-actin-Renilla
luciferase reporter construct used as transfection efficiency
control (Renilla) and pDisplay (Invitrogen); (B) TLR2, TLR1,
CD14, CD36, MD-2, Firefly, Renilla and pDisplay; (C) TLR4,
CD14, CD36, MD-2, Firefly, Renilla and pDisplay; and (D)
Firefly, Renilla and pDisplay (Empty vector). The amounts of
constructs per well were: 0.20 µg mouse TLR2 or TLR4 or TLR6,
0.80 µg mouse TLR1, 0.20 µg mouse MD-2, CD14 and CD36,
0.20 µg Firefly, 6.60 ng Renilla. To reach a constant DNA mass
of 2.00 µg, different amounts of the pDisplay were then added
in each well. Cells were grown for 24 h, detached by trypsin
treatment and incubated for 24 h in 96-well plates (4× 104/well)
at 37◦C, 5% CO2.
NF-κB Activation Assessment by
Luciferase Reporter Assay
HEK 293A transfected cells were stimulated for 4 h at 37◦C,
5% CO2, with 0.5, 5, or 50µg/ml of RA, RAinc, K98, and
K98inc or 100 ng/ml lipopolysaccharide (LPS, TLR4 ligand) or
1 nM Pam3CSK4 (P3C, TLR2/1 ligand) or 10 ng/ml fibroblast-
stimulating lipopeptide-1 (FSL-1, TLR2/6 ligand) (InvivoGen,
San Diego, CA, USA) or 0.5% EtOH (vehicle) as control.
Cells were then washed with PBS, lysed in passive lysis
buffer (Promega, Madison, WI, USA) and NF-κB activation
was evaluated through luciferase activity determination using
the Dual-Luciferase Reporter Assay System, according to the
manufacturer’s instructions (Promega). Relative luminescence
units were determined with the SpectraMax luminometer
(Thermo Scientific, Meridian Rd, Rockford, IL, USA) and
luciferase activity was expressed as Firefly/Renilla luciferase
activity ratio.
IL-8 Chemokine Determination
HEK 293A transfected cells were stimulated for 20 h with 0.5,
5, or 50µg/ml of RA, RAinc, K98, and K98inc or 100 ng/ml
LPS or 1 nM P3C or 10 ng/ml FSL-1 or 0.5% EtOH (vehicle)
as control. IL-8 levels were determined in cell supernatants
by ELISA using Human CXCL8/IL-8 DuoSet ELISA Kit (R&D
Systems, Minneapolis, MN, USA).
Murine Peritoneal Macrophages
Peritoneal macrophages were obtained from BALB/c mice as
previously described (Gimenez et al., 2010) and cultured in
RPMI 1640 medium supplemented with 100 U/ml penicillin and
100µg/ml streptomycin at 37◦C, 5% CO2. Local guidance for
animal care and experimentation were followed throughout this
research according to protocols approved by the Universidad
de Buenos Aires’s Institutional Committee for the Care and
Use of Laboratory Animals (CICUAL) in accordance with the
Council for International Organizations of Medical Sciences
(CIOMS) and International Council for Laboratory Animal
Science (ICLAS) international ethical guidelines for biomedical
research involving animals.
Determination of Lipid Bodies (LB)
Macrophages (1 × 106/well) were plated onto coverslips in 24-
well plates and stimulated with 50µg/ml of the different lipid
extracts or 0.5% EtOH (vehicle) as negative control or 100 ng/ml
LPS as positive control for 24 h at 37◦C, 5% CO2. For LB
quantification, cells were fixed in 4% formaldehyde while still
moist, washed and stained with 0.5% Oil red O (Melo et al.,
2011). Cell morphology was visualized and LB were counted in
50 consecutive macrophages using phase contrast microscopy
(100x, Nikon Eclipse E600).
COX-2 Expression
For COX-2 immunoblot analysis, 1 × 106 macrophages/well
were plated in 24-well plates and stimulated with 50µg/ml of
the different lipid extracts or 0.5% EtOH (vehicle) as negative
control or 100 ng/ml LPS as positive control for 24 h at 37◦C,
5% CO2. Cells were then washed with PBS, homogenized
with lysis buffer (50mM NaH2PO4, 300mM NaCl, pH 8) and
suspended in Laemmli sample buffer + 100mM DTT, boiled
and stored at −20◦C until used. Immunoblot analyses were
performed as previously reported using goat IgG anti COX-2
(1:200 v/v, Santa Cruz Biotechnology, CA, USA), and anti-goat
IgG-HRP conjugate (1:2000 v/v, Santa Cruz Biotechnology, TX,
USA) (Gimenez et al., 2016). For loading control, detection of
β-actin was performed in the same membranes. The COX-2
band intensity was quantified by densitometry using Gel-Pro R©
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Analyzer 4.0 and normalized to that of the corresponding β-actin
band.
Nitric Oxide Determination
Macrophages (5 × 105/well) were plated in 96-well plates and
stimulated with 50µg/ml of the different lipid extracts or 0.5%
EtOH (vehicle) as negative control or 100 ng/ml LPS as positive
control, in the presence of 600 pg/ml IFN-γ, for 48 h at 37◦C, 5%
CO2. NO levels were determined in cell supernatants as nitrite
production using the Griess reaction and absorbance at 540 nm
(Gimenez et al., 2013).
TNF-α Measurement
Macrophages (1 × 106/well) were plated in 24-well plates and
stimulated with 50µg/ml of the different lipid extracts or 0.5%
EtOH (vehicle) as negative control, or 100 ng/ml LPS as positive
control, for 24 h at 37◦C, 5% CO2. TNF-α levels were determined
by ELISA in cell supernatants according to manufacturer’s
protocol (R&D Systems, Minneapolis, MN, USA).
Statistical Analysis
The results were expressed as mean ± SEM. Data were
analyzed by one-way analysis of variance (ANOVA) followed
by Bonferroni’s Multiple Comparison Test using GraphPad
Prism 4.0. Statistically significant differences were represented as
∗p < 0.05; ∗∗p < 0.01 and ∗∗∗p < 0.001.
RESULTS
T. cruzi Total Lipid Extracts Possess
Quantitative Differences in Their Lipid
Profiles
Previously, we reported differences in the profiles of total lipid
extracts from T. cruzi amastigotes of the highly virulent RA
strain (RA) with respect to those from parasites incubated
for 12 h at 37◦C (RAinc). In RA the main phospholipid was
phosphatidylcholine (PC) which was degraded when parasites
were incubated, observing a simultaneous and significant
increase in FFA generation, facts that could be attributed
to parasite phospholipase and lysophospholipase degrading
activities (Wainszelbaum et al., 2001). Herein, we analyzed by
TLC the total lipid extract from T. cruzi amastigotes of the low
virulence strain K98 (K98) as well as that corresponding to
incubated parasites (K98inc). Figure 1A shows that K98 and
K98inc possess quantitative differences in their lipid profiles,
being phosphatidylethanolamine (PE) the main phospholipid in
both of them. The densitometric analyses indicated a significant
decrease in PE, lysophosphatidylethanolamine (LPE) and
lysophosphatidylcholine (LPC) (∼36, 48, and 56% respectively)
with a concomitant increase in FFA (∼ 59%) in K98inc with
respect to K98 (Figure 1B).
To determine the identity of the fatty acids (FA) present
in the different T. cruzi extracts, we performed a GC–MS
FIGURE 1 | Analysis of the lipid composition of K98 and K98inc. (A) K98 and K98inc were separated by TLC using a double solvent system. For mass determination,
plates were sprayed with 10% CuSO4 in 8% H3PO4 and charred by exposure to 150
◦C for 13min; lipids were identified by comparison with authentic standards. The
TLC plate is representative of three independent experiments performed with independent batches of lipid extracts. (B) Densitometric analyses of the TLC plate were
performed and the percentage of each lipid fraction was determined with respect to total lipids for each lane. Each bar represents the mean ± SEM of triplicate
determinations. O, origin; LPC, Lysophosphatidylcholine; PC, Phosphatidylcholine; LPE, Lysophosphatidylethanolamine; PE, Phosphatidylethanolamine; CHO,
Cholesterol; DG, Diacylglycerol; FFA, Free fatty acids; TG, Triacylglycerol; SE, Steryl esters; K98, total lipid extract from amastigotes of K98 T. cruzi strain; K98inc, total
lipid extract from incubated amastigotes of K98 T. cruzi strain; *, ** and *** statistically significant (p < 0.05, p < 0.01, and p < 0.001 respectively).
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analysis (Table 1). The most abundant FAs for all the extracts
were stearic acid and palmitic acid followed by lignoceric acid
(Figure 2). As regards RA vs K98, we determined differences
in the relative amounts of the main FA: RA presented higher
levels of palmitic acid, lignoceric acid and oleic acid with
respect to K98 (∼36, 40, and 31% higher, respectively), whereas
4,7,10,13,16,19-docosahexaenoic acid, elaidic acid, linoleic acid,
arachidonic acid and myristic acid were present in higher
proportions in K98 than RA (∼72, 99, 18, 76, and 24% higher,
respectively). Considering K98inc vs. K98, we detected a ∼29%
increase in stearic acid in the former, whereas RAinc vs RA
displayed a ∼9% increase in stearic acid and 5% in palmitic acid
(Table 1).
Amastigote Phospholipids Are Hydrolyzed
by T. cruzi PLA1
To demonstrate if T. cruzi PLA1 participates in the degradation
of endogenous phospholipids observed after homogenates
TABLE 1 | Fatty acids analyses of RA, RAinc, K98 and K98inc. The analyses of
the fatty acids (FA) fractions of all T. cruzi total lipid extracts were performed by
GC–MS.
Compounds % over total FA
K98 K98inc RA RAinc
Lauric acid 1.02 0.00 0.37 0.17
Myristic acid 2.24 0.37 1.81 1.36
Pentadecanoic acid 0.47 0.15 0.63 0.34
Palmitoleic acid 0.23 0.16 0.43 0.36
Palmitic acid 22.59 21.06 30.71 32.29
Margaric acid 0.66 0.50 0.47 0.47
Linoleic acid 4.67 3.62 3.95 3.18
Oleic acid 4.09 3.33 5.36 4.60
Elaidic acid 3.36 1.34 1.69 1.55
Stearic acid 33.07 42.79 34.75 37.78
Arachidonic acid 1.85 1.64 1.05 0.90
8,11,14-Eicosatrienoic acid 0.42 0.38 0.29 0.27
11,14-Eicosadienoic acid 0.21 0.00 0.00 0.00
Arachidic acid 0.47 0.31 0.20 0.27
4,7,10,13,16-Docosapentaenoic acid 1.87 1.57 1.41 1.14
4,7,10,13,16,19-Docosahexaenoic acid 3.74 3.20 2.17 1.76
7,10,13,16-Docosatetraenoic acid 1.41 1.26 0.53 0.45
7,10,13,16,19-Docosapentaenoic acid 1.31 1.21 0.62 0.52
Erucic acid 0.37 0.30 0.26 0.23
Behenic acid 0.84 0.57 0.48 0.41
Tricosanoic acid 0.20 0.19 0.13 0.15
Nervonic acid 0.77 0.83 0.42 0.38
Lignoceric acid 5.27 5.90 7.39 6.88
Cerotic acid 0.58 0.47 0.80 0.70
Cholesterol 8.29 8.83 4.08 3.86
The components were identified by comparing their mass spectra with those of the library
NIST05 contained in the computer’s mass spectrometer. The FA are listed in ascending
order according to the retention time and their content is presented as the percentage of
each FA with respect to the total FA present in each sample.
incubation, two different experimental approaches were
performed. First, we evaluated the effect of recombinant
T. cruzi PLA1 on amastigote total lipids. For this purpose, this
enzyme was subcloned into a baculovirus expression system
(Supplementary Figure 1) and then purified (Supplementary
Figure 2); lipids were extracted from amastigote homogenates
in order to remove native T. cruzi PLA1 which could hydrolyze
endogenous phospholipids, and finally, lipids were incubated
with recombinant T. cruzi PLA1. Figure 3A shows that
this enzyme significantly hydrolyzed parasite lipids and the
densitometric analyses displayed a significant decrease in
PC and PE (∼35 and 20%, respectively) with a concomitant
increase in LPC and FFA (∼218 and 88%, respectively),
with respect to control (Figure 3B). Second, we investigated
whether pre-treatment of amastigote homogenates with
chlorpromazine, a T. cruzi PLA1 inhibitor (Wainszelbaum
et al., 2001), could abrogate the lipid modifications previously
determined (Figure 1). Figure 3C shows that this compound
significantly inhibited PC and PE degradation as well as FFA and
LPC generation, in a dose dependent manner. Considering that
LPE and chlorpromazine presented a similar retention factor, we
were not able to analyze and discriminate any variations in this
spot. Densitometric analyses showed that the variations observed
in PC, PE, LPC, and FFA were significant with respect to control
(Figure 3D).
RA and K98 Triggered the Highest NF-κB
Activation and IL-8 Secretion via TLR2/6
We next analyzed if RA, K98, RAinc and K98inc were able
to induce NF-κB activation and IL-8 secretion as well as
which of the TLRs combinations in HEK transfected cells
(TLR2/6, TLR2/1, or TLR4), were involved in these processes.
Figure 4A shows that all lipid extracts induced NF-κB activation
in HEK cells through the heterodimeric complex TLR2/6
and in a dose-dependent manner. In particular, RA and
K98 generated significantly higher levels of activation with
respect to RAinc and K98inc (∼1.60 and 2.98-fold higher,
respectively). In contrast, no differences in NF-κB activation
were observed respect to control when TLR2/1 or TLR4
transfected cells were stimulated with each lipid extract even
at the higher dose, whereas treatments with P3C or LPS were
able to activate NF-κB, thus confirming cell responsiveness
(Figures 4B,C).
Concerning IL-8, similar results to that determined for
NF-κB activation were obtained, as all lipid extracts were
able to induce this chemokine release also through TLR2/6
and in a dose-dependent manner. Once again, RA and K98
generated significantly higher levels of IL-8 release with respect
to RAinc and K98inc (∼1.40 and 3.50-fold higher, respectively)
(Figure 5A) and neither TLR2/1 nor TLR4 were involved in lipid
recognition (Figures 5B,C). Noteworthy, no differences in NF-
κB activation and IL-8 release were observed in cells transfected
with the empty vector and stimulated with the same lipid extracts
or classical TLR ligands with respect to control, indicating that
all the results here obtained were dependent on TLR expression
and not mediated by other receptors present in HEK cells
(Figures 4D, 5D).
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FIGURE 2 | The most abundant fatty acids present in the different T. cruzi amastigote lipid extracts were determined by Gas Chromatography–Mass Spectrometry
(GC-MS) analyses and are displayed in cake graph format. RA: total lipid extract from amastigotes of RA T. cruzi strain; RAinc: total lipid extract from incubated
amastigotes of RA T. cruzi strain; K98: total lipid extract from amastigotes of K98 T. cruzi strain; K98inc: total lipid extract from incubated amastigotes of K98 T. cruzi
strain.
RA and K98 Induced LB Formation and
COX-2 Expression
It is known that T. cruzi infection induces in macrophages
LB formation, structural markers of inflammation (Melo and
Dvorak, 2012). We here demonstrated that both RA and
K98 were able to induce LB formation in murine peritoneal
macrophages with respect to control (Figure 6A). In the case
of RAinc, LB generation was significantly inhibited with respect
to control and when compared with RA, the reduction in the
number of LB was ∼4.57 folds (Figures 6A,B). K98inc had no
effect with respect to control and we observed a reduction in LB
numbers of ∼1.74-fold lower with respect to K98 (Figure 6B).
Considering that LB contain eicosanoid-forming enzymes such
as COX-2, we then investigated if the lipid extracts were
able to induce this enzyme expression in murine peritoneal
macrophages. Results show that both RA and K98 induced COX-
2 expression with respect to control, whereas RAinc and K98inc
did not. When comparing RAinc vs RA and K98inc vs K98, we
observed a reduction in COX-2 levels of ∼3.18 and 2.84 folds
respectively (Figures 6C,D).
RA and K98 Stimulated NO Production
Thereafter, we evaluated if all lipid extracts were able to promote
NO production, a major effector molecule with trypanocidal
activity, in murine peritoneal macrophages (Gutierrez et al.,
2009). Results indicate that RA and K98 induced a significant
NO release, whereas RAinc and K98inc did not stimulate
the production of this soluble factor compared to control.
Particularly, RA and K98 induced ∼1.79 and 1.83-fold higher
NO levels with respect to their corresponding incubated lipid
extracts, RAinc and K98inc (Figure 7).
RA and K98 Induced TNF-α Release
It has been reported that during the initial steps of T. cruzi
infection a strong inflammatory response is triggered with
production of cytokines, such as TNF-α, which activate cells
for parasite control (Andrade et al., 2014). In view of that,
we here analyzed if the lipid extracts were able to promote
the production of this pro-inflammatory cytokine in murine
peritoneal macrophages. Figure 8 shows that both RA and K98
induced significant levels of TNF-α with respect to control,
in contrast to RAinc and K98inc which had no effect. The
comparison between RAinc vs RA and K98inc vs. K98 displayed
a reduction in this cytokine level of ∼8.91 and 11.33 folds,
respectively.
DISCUSSION
This is a novel report that describes the biological effect of
total lipid extracts from amastigotes of two T. cruzi strains,
which belong to different DTUs and possess polar biological
behavior: RA (Tc VI, high virulence) and K98 (Tc I, low
virulence) (González Cappa et al., 1980, 1981; Zingales et al.,
2009). Herein, we analyzed the lipid composition of the total lipid
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FIGURE 3 | Amastigote phospholipids are hydrolyzed by T. cruzi PLA1. Effect of recombinant T. cruzi PLA1 on amastigotes total lipids. (A) Amastigotes total lipid
suspensions from T. cruzi RA strain (5 mg/ml) were incubated with 700µg/ml recombinant T. cruzi PLA1 or elution buffer as control, at 37
◦C for 18 h. Lipids were
extracted and separated by TLC and identified by comparison with commercial standards. The TLC plate is representative of two independent experiments performed
with independent batches of lipid extracts. Mass determination was carried out by charring. (B) Densitometric analyses of the TLC plate were performed with
Gel-Pro® Analyzer 4.0 and the percentage of each lipid fraction was determined with respect to total lipids for each lane. Each bar represents the mean ± SEM of
triplicate determinations. (C) Effect of chlorpromazine on native T. cruzi PLA1. Amastigote homogenates were pre-incubated with the T. cruzi PLA1 inhibitor
chlorpromazine (CPZ) at different concentrations (2.5, 5.0, and 10.0mM) at room temperature and then incubated for 5 h at 37◦C. Lipids were then extracted and
separated by TLC, lipid spots identified by comparison with commercial standards and mass determination was carried out by charring. As controls, lipids from
amastigote homogenates without CPZ, non-incubated (T0) and 5 h incubated (T5), were included. (D) Densitometric analyses of the TLC plates were performed with
Gel-Pro® Analyzer 4.0 and the percentage of each lipid fraction was determined over PE + PC + LPC + FFA content for each lane. Each bar represents the mean ±
SEM of triplicate determinations of 2 independent assays. O, origin; LPC, Lysophosphatidylcholine; PC, Phosphatidylcholine; LPE, Lysophosphatidylethanolamine;
PE, Phosphatidylethanolamine; CHO, Cholesterol; DG, Diacylglycerol; FFA, Free fatty acids; TG, Triacylglycerol; SE, Steryl esters; TcPLA1, Trypanosoma cruzi
Phospholipase A1; * and *** statistically significant (p < 0.05 and p < 0.001).
extracts from these parasites and demonstrated that although RA
and K98 had different content of phospholipids (PC and PE)
and FA, they were able to induce a similar pro-inflammatory
response. Remarkably, when we evaluated the effect of RAinc
and K98inc, we determined the loss/decrease of the pro-
inflammatory response previously detected with RA and K98,
a fact that could be attributed to the quantitative changes
in the FFA, phospholipid and lysophospholipid fractions. In
this regard, we here demonstrated that T. cruzi PLA1, an
enzyme capable of hydrolyzing zwitterionic phospholipids such
as PC and PE (Wainszelbaum et al., 2001), participates in
these lipid modifications. Furthermore, the quantitative decrease
in lysophospholipids observed in RAinc and K98inc could be
attributed to the lysophospholipase activity that T. cruzi PLA1
also possesses, since no lysophospholipase A inhibitors were used
(Wainszelbaum et al., 2001; Belaunzarán et al., 2013).
Lysophospholipids, mediators in the synthetic pathways of
various phospholipids and structural components, can also act
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FIGURE 4 | RA and K98 triggered the highest NF-κB activation via TLR2/6. HEK 293A cells were transfected with four different combinations of plasmid constructs:
(A) TLR2, TLR6, CD14, CD36, MD-2, Firefly luciferase reporter construct driven by a NF-κB -dependent promoter (Firefly), β-actin-Renilla luciferase control reporter
(Renilla), and pDisplay; (B) TLR2, TLR1, CD14, CD36, MD-2, Firefly, Renilla, and pDisplay; (C) TLR4, CD14, CD36, MD-2, Firefly, Renilla, and pDisplay; and (D) Firefly,
Renilla, and pDisplay (empty vector). Cells were then stimulated for 4 h with 0.5, 5, or 50µg/ml of RA, RAinc, K98 and K98inc or 100 ng/ml LPS or 1 nM P3C or
10 ng/ml FSL-1 or 0.5% EtOH (control). NF-κB activation was evaluated through luciferase activity determination and expressed as Firefly/Renilla ratio. (B–D) show the
results of cells stimulated with the highest concentration of each lipid extract (50µg/ml). Each bar represents the mean ± SEM of triplicate determinations from three
independent experiments. FSL-1, fibroblast-stimulating lipopeptide-1; LPS, lipopolysaccharide; P3C, Pam3CSK4; RA, total lipid extract from amastigotes of RA
T. cruzi strain; RAinc, total lipid extract from incubated amastigotes of RA T. cruzi strain; K98: total lipid extract from amastigotes of K98 T. cruzi strain; K98inc: total
lipid extract from incubated amastigotes of K98 T. cruzi strain; *** statistically significant (p < 0.001).
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FIGURE 5 | RA and K98 triggered the highest IL-8 secretion via TLR2/6. HEK 293A cells were transfected with four different combinations of plasmid constructs: (A)
TLR2, TLR6, CD14, CD36, MD-2, Firefly luciferase reporter construct driven by a NF-κB -dependent promoter (Firefly), b-actin-Renilla luciferase control reporter
(Renilla), and pDisplay; (B) TLR2, TLR1, CD14, CD36, MD-2, Firefly, Renilla, and pDisplay; (C) TLR4, CD14, CD36, MD-2, Firefly, Renilla, and pDisplay; and (D) Firefly,
Renilla, and pDisplay (empty vector). Cells were then stimulated with 0.5, 5, or 50µg/ml of RA, RAinc, K98 and K98inc or 100 ng/ml LPS or 1 nM P3C or 10 ng/ml
FSL-1 or 0.5% EtOH (control). After 20 h of incubation, IL-8 levels were determined in the supernatants by ELISA. Each bar represents the mean ± SEM of triplicate
determinations from three independent experiments; FSL-1, fibroblast-stimulating lipopeptide-1; LPS, lipopolysaccharide; P3C: Pam3CSK4; RA, total lipid extract
from amastigotes of RA T. cruzi strain; RAinc: total lipid extract from incubated amastigotes of RA T. cruzi strain; K98, total lipid extract from amastigotes of K98
T. cruzi strain; K98inc, total lipid extract from incubated amastigotes of K98 T. cruzi strain; ** and *** statistically significant (p < 0.01 and p < 0.001 respectively).
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FIGURE 6 | RA and K98 induced the formation of lipid bodies (LB) and COX-2 expression. Macrophages were stimulated for 24 h with 50µg/ml of RA, RAinc, K98 or
K98inc; 0.5% EtOH (control) or 300 ng/ml LPS and then staining with Oil red O. (A) Lipid bodies in macrophages stimulated with RA or RAinc and control cells.
(B) Lipid bodies were counted in 50 consecutive macrophages and each bar represents the mean ± SEM from three independent experiments. (C) Immunoblot
analysis of COX-2 expression and β-actin (loading control) are representative of three independent experiments. (D) The intensity of COX-2 bands was quantified by
densitometry and normalized to the intensity to the corresponding β-actin band. Data represent the mean ± SEM of triplicate determinations. RA, total lipid extract
from amastigotes of RA T. cruzi strain; RAinc, total lipid extract from incubated amastigotes of RA T. cruzi strain; K98, total lipid extract from amastigotes of K98
T. cruzi strain; K98inc, total lipid extract from incubated amastigotes of K98 T. cruzi strain, AU, arbitrary units; * and *** statistically significant (p < 0.05 and p < 0.001).
FIGURE 7 | RA and K98 stimulated NO production. Macrophages were
stimulated with 50µg/ml of RA, RAinc, K98 and K98inc or 300 ng/ml LPS or
0.5% EtOH (control), in the presence of 600 pg/ml IFN-γ, for 48 h. NO levels
were determined in supernatants as nitrite production using the Griess
reaction. Each bar represents the mean ± SEM of triplicate determinations
from three independent experiments. RA, total lipid extract from amastigotes
of RA T. cruzi strain; RAinc, total lipid extract from incubated amastigotes of
RA T. cruzi strain; K98, total lipid extract from amastigotes of K98 T. cruzi
strain; K98inc: total lipid extract from incubated amastigotes of K98 T. cruzi
strain; *** statistically significant (p < 0.001).
as signaling molecules (Sowinska et al., 2016). A growing body
of evidence suggests that LPC plays a role in the regulation of cell
immune responses and chronic diseases progression (Matsumoto
et al., 2007; Silva-Neto et al., 2016). Besides, it has been proposed
that LPC is a dual activity molecule, able to trigger a classical
pro-inflammatory phenotype as well as to induce an anti-
inflammatory phenotype in macrophages (Carneiro et al., 2013;
Assunção et al., 2017). As concerns T. cruzi LPC, this parasite
FIGURE 8 | RA and K98 induced TNF-α release. Macrophages were
stimulated with 50µg/ml of RA, RAinc, K98 and K98inc or 300 ng/ml LPS or
0.5% EtOH (control), for 24 h. TNF-α levels were determined by ELISA in cell
supernatants. Each bar represents the mean ± SEM of triplicate
determinations from three independent experiments. RA: total lipid extract
from amastigotes of RA T. cruzi strain; RAinc: total lipid extract from incubated
amastigotes of RA T. cruzi strain; K98: total lipid extract from amastigotes of
K98 T. cruzi strain; K98inc: total lipid extract from incubated amastigotes of
K98 T. cruzi strain; *** statistically significant (p < 0.001).
synthesizes at least five species of this molecule and only sn-
1 C18:1(D9)-LPC is able to promote rabbit platelet aggregation
(Gazos-Lopes et al., 2014). Therefore, we could not discard the
possibility that RA and K98 might possess this bioactive LPC
which could be degraded by lysophospholipase activity during
incubation and as consequence its content reduced in RAinc
and K98inc. As regards FA, other bioactive molecules present in
T. cruzi lipid extracts, one of the majors was palmitic acid, which
can display a pro-inflammatory effect (Ajuwon and Spurlock,
2005). Stearic acid, with known anti-inflammatory effect (Pan
et al., 2010; Othman Razi et al., 2015), was another major
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FA in T. cruzi lipid extracts and at variance was increased
in RAinc and K98inc, a fact that could contribute to the
reduction of the pro-inflammatory effects induced by RA and
K98. Besides, other FAs present in low quantities as well as
other phospholipids/lysophospholipids could also contribute to
the global effect observed with each T. cruzi lipid extract.
In the present work we demonstrated, in HEK transfected
cells, that the TLR2/6 heterodimer participates in the recognition
of all the lipid extracts from both T. cruzi strains, but not TLR2/1
and TLR4. It has been described that synthetic LPC signals via
TLR2 and TLR4 and the schistosomal-derived LPC via TLR2
(Magalhães et al., 2010; Carneiro et al., 2013), thus allowing us
to suggest that the LPC present in the T. cruzi lipid extracts
here studied could contribute to TLR2/6 stimulation. As regards
known T. cruzi TLR2/6 ligands, up to now there are no reports
about molecules of exclusively lipid nature, nevertheless complex
glycolipids like trypomastigote mucin GPI anchors, especially the
unsaturated fatty acid at the sn-2 position, have been described
as potent stimulators of this heterodimer (Cardoso et al., 2016).
In vitro stimulation of TLR2/6 by T. cruzi GPI-mucins leads to
the production of pro-inflammatory cytokines such as IL-12 and
TNF, as well as NO, which are related to a Th1-focused immune
response that is important to control parasitemia and tissue
parasitism (Cardoso et al., 2016). Although, in vitro stimulation
of TLR2/6 by T. cruzi GPI-mucins induces pro-inflammatory
cytokines release, in vivo assays showed that TLR2 could play
an immunoregulatory role during T. cruzi infection (Cardoso
et al., 2016). Concerning FFAs present in T. cruzi lipid extracts,
these molecules might also contribute to the TLR2/6 stimulation
here observed, since it has been described that they can activate
TLR4, TLR2/1, or TLR2/6 leading to stimulation of specific
signaling pathways followed by expression of TNFα, IL-6, and
MCP-1 (Neacsu et al., 2013). Further studies will elucidate
which particular lipid molecules, present in these lipid extracts,
participate in the immunomodulation via TLR2/6. It is well
known that in the TLRs pathways several transcription factors
such as NF-κB, among others, are activated and induce the release
of inflammatory cytokines, chemokines and NO (Shoda et al.,
2001). In this concern, it has been reported that T. cruzi infection
of murine cardiomyocytes triggers signal transduction pathways
that leads to NF-κB activation, among other transcription factors
(Huang et al., 2003). Herein, we determined in HEK transfected
cells that all T. cruzi lipid extracts promoted the activation of
NF-κB pathway specifically via TLR2/6 with the resulting IL-8
secretion, major chemoattractant of neutrophils. Interestingly,
the fact that RAinc and K98inc induced a significantly lower
NF-κB activation and IL-8 secretion with respect to RA and
K98, could be attributed to the loss of some bioactive pro-
inflammatory components or to the generation of compounds
with anti-inflammatory effect, as previously suggested.
Macrophages are crucial cells of innate immunity that can
recognize pathogens and induce LB formation, lipid mediators
and cytokine release. During T. cruzi infection it has been
reported that LB formation and COX-2 expression increase in
macrophages and that LB generation occurs through a TLR2
dependent mechanism (D’Avila et al., 2011). The present finding
that RA and K98 induced in macrophages the increase in
LB number, together with the fact that all lipid extracts were
recognized by TLR2/6 in HEK transfected cells, led us to propose
that LB formation and COX-2 expression induced by T. cruzi
lipids can also occur through a TLR2/6 dependent mechanism.
Remarkably, in the case of RAinc stimulated macrophages, LB
formation was significantly reduced with respect to control
cells suggesting the presence in this extract of hydrolyzed lipid
molecules that could inhibit the formation of these structural
markers of inflammation. Besides, the findings that only RA
and K98 were able to induce NO secretion and TNF-α release,
pro-inflammatory mediators regulated via NF-κB, support again
our point of view that the differences in the lipid composition
of RAinc and K98inc here detected could be related to their
reduced biological effect. On the other hand, since it has been
described that macrophages possess a secreted PLA2, we cannot
rule out that this enzyme could be up-regulated by T. cruzi
lipids during the in vitro assays here described, and consequently
contribute to the generation of bioactive lipids (Ruipérez et al.,
2007).
Collectively, our results point to a role of T. cruzi lipids
in the induction of a pro-inflammatory response through the
TLR2/6 pathway that could contribute to the control of infection
and host survival. Since up to now there is no effective vaccine
against this parasite, research has focused on the identification
and characterization of PAMPs from T. cruzi to offer new
TLR agonists as possible adjuvant molecules in new generation
vaccines. Further studies of T. cruzi lipids will elucidate which
are the inmunomodulating molecules present in these extracts
that could be considered as potential candidates to be tested in
therapeutic approaches or immunoprophylactic strategies.
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